Pablo Tebas, MD
University of Pennsylvania · Hospital of the University of Pennsylvania CRS · Penn Therapeutics CRS
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Pablo Tebas, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:10 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05293249 · dMAbs for Prevention of COVID-19Pablo Tebas · completed · Healthy Volunteers · principal investigator
- Ph1NCT03831503 · A Study of INO-A002 in Healthy Dengue Virus-naive AdultsUniversity of Pennsylvania · completed · Healthy Volunteers · principal investigator
- Ph4NCT03761953 · Oritavancin for Staphylococcus Aureus Infections in Opioid UsersUniversity of Pennsylvania · withdrawn · Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis · principal investigator
- Ph2NCT03739996 · Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1National Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- Ph1NCT03705169 · Pharmacokinetics and Safety of SAR441236National Institute of Allergy and Infectious Diseases (NIAID) · terminated · HIV-1-infection · study chair
- Ph1NCT03617198 · CD4 CAR+ ZFN-modified T Cells in HIV TherapyUniversity of Pennsylvania · active not recruiting · Hiv · principal investigator
- Early Ph1NCT03020524 · Autologous CD4 T-Cells in HIV (C34-CXCR4)University of Pennsylvania · completed · Hiv · principal investigator
- Ph1NCT02463227 · Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody (VRC01) in HIV-Infected Adults Undergoing a Brief Treatment InterruptionNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- Ph1NCT02154360 · Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected SubjectsUniversity of Pennsylvania · completed · HIV Infection · principal investigator
- Ph1NCT01300988 · Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg DoseUniversity of Pennsylvania · completed · HIV Infection · principal investigator
- Ph4NCT01262846 · Improving Immunogenicity of Influenza Vaccine in HIV Infected IndividualsUniversity of Pennsylvania · completed · HIV Infection · principal investigator
- Ph1NCT01082692 · Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult ParticipantsInovio Pharmaceuticals · completed · HIV-1 Infection, HIV Infections · principal investigator
- Ph4NCT00976040 · Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal MeningitisBotswana-UPenn Partnership · completed · Cryptococcal Meningitis, HIV Infections · principal investigator
- Ph1NCT00842634 · Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIVUniversity of Pennsylvania · completed · HIV, HIV Infections · principal investigator
- Ph1NCT00775424 · PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV InfectionUniversity of Pennsylvania · completed · HIV Infection · principal investigator
- Ph2NCT00594880 · Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 InfectionThe Wistar Institute · completed · HIV Infections · principal investigator
- Ph2NCT00528593 · Epoetin Alfa for HIV-Associated Neuropathy TrialWashington University School of Medicine · withdrawn · HIV Infections, Neuropathy · principal investigator
- Ph1NCT00428519 · Effects of Treatment With Aprepitant (Emend®) in HIV Infected IndividualsUniversity of Pennsylvania · completed · HIV Infections · principal investigator
- Ph1NCT00295477 · Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIVUniversity of Pennsylvania · completed · HIV · principal investigator
- N/ANCT00028314 · Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV PatientsNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections, Lipodystrophy, Wasting Disease · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Project 2U01MH090325 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI Steven Daniel Douglas · fiscal years 2009 to 2013Named on NCT01300988, NCT00428519
- Antiviral activity of Peg-IFN alpha in chronic HIV-1U01AI065279 · NIAID · WISTAR INSTITUTE · PI Luis J Montaner · fiscal years 2005 to 2009Named on NCT00594880
- NEUROLOGIC AIDS RESEARCH CONSORTIUMU01NS032228 · NINDS · WASHINGTON UNIVERSITY · PI DAVID B CLIFFORD · fiscal years 2003 to 2008Named on NCT00528593
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.